| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 59.51 | 10.8% |
| Total Income | 60.11 | 11.7% |
| Expenditure | 52.06 | 4.3% |
| PBT | 8.05 | 41.0% |
| Net Profit | 5.99 | 41.1% |
| OPM | -5.65% | 7.82pp |
| NPM | 9.96% | 4.96pp |
| EPS | 1.18 | 39.2% |
Suraksha Diagnostic Limited Reports 14.4% YoY Growth in Total Income for 9M FY25, EBITDA Up by 22.4% and Margin Expansion of 229 bps Y-o-Y
09 Feb 2025 · 9 Feb 2025, 12:33 am
Summary
Suraksha Diagnostic Limited, the largest integrated diagnostic chain in East India, announced its unaudited financial results for the quarter and nine months ended December 31, 2024. The company reported a 14.4% YoY growth in total income for the nine months ended FY25, with EBITDA up by 22.4% and a margin expansion of 229 bps Y-o-Y to reach 34.8%. The strong results are driven by operational efficiency and strategic execution, despite external factors like the doctors' strike affecting operations in Q3 FY25.
Key Highlights
- 1
Revenue from Operations: Q3 FY25 saw a 14.8% YoY growth, and 9M FY25 reported a 14.4% YoY growth.
- 2
EBITDA: Q3 FY25 EBITDA increased by 16.7% YoY, with a 31.7% EBITDA margin. 9M FY25 EBITDA grew by 22.4% YoY, with a 34.8% EBITDA margin.
- 3
Profit After Tax (PAT): Q3 FY25 PAT grew by 31.9% YoY, with a 10.1% PAT margin. 9M FY25 PAT increased by 41.7% YoY.
Management Comments
Ms Ritu Mittal
Joint Managing Director & CEO
We reported strong performance during the third quarter and nine months ended FY25 and remain poised to continue to deliver strong revenue growth and margins over the long term. Given the expectations, our performance was curtailed in current quarter due to external factors such as the doctors’ strike, which had a lingering adverse impact on our operations during the quarter. The seasonal weakness during the third quarter reflected in a pull-back in our top-line and EBITDA levels, when comparing on a quarter-on-quarter basis. However, margins were partially supported on a year-over-year basis on the back of efficient cost control measures. We remain steadfast in our focus on internal growth through the addition of new centers as well as exploring inorganic growth opportunities. These focus areas position us well to further strengthen our dominance in the Eastern region of India. We expect to continue to leverage our strong presence to drive a pick-up in the business and margins going forward.
Informational and educational content only. Not investment advice.